UNFUCG
DashboardSearchChatBookmarksNotificationsActivityPremiumProfile
?
Home
Search
Chat
Saved
Profile
Episode
Google I/O 2026 Releases and Cerebras’ $95B IPO w/ Andrew Feldman | EP #256
~170 min
Episode Brief·YouTube

Google I/O 2026 Releases and Cerebras’ $95B IPO w/ Andrew Feldman | EP #256

Peter Diamandis
Watch on YouTube Add to chat My bookmarks← All sources

TL;DR

The four things you'd lose by not watching

4 items

TL;DR

The four things you'd lose by not watching

4 items
1

Google I/O 2026 revealed a company fully committed to AI: capex surged 6x to $180-190B/year, Gemini reached 900M users, and new products like Gemini Omni (video generation), anti-gravity 2.0 (agentic coding), and Gemini Spark (personal agent) show Google leveraging its distribution to compete with frontier labs.

2

Cerebras Systems, maker of wafer-scale AI chips for fast inference, pulled off the third-largest tech IPO ever, up 68% to a $95B market cap, after decades of solving hard manufacturing problems and now riding an explosion of demand for affordable, high-throughput inference.

3

Andre Karpathy joined Anthropic to work on pre-training research, arguing that staying at a frontier lab is essential to avoid 'drifting' and to shape the next few critical years of LLM development.

4

A Fountain Life health segment presented protocol for dementia prevention: lifestyle changes (diet, exercise, sleep) improved brain age in 46% of members over 13 months.

Sign in to share feedback

Tell us if this brief hit the mark or missed it — feedback feeds back into the next iteration of the prompt.

Topics covered

google-io-2026gemini-omnigemini-3.5-flashsynthidanti-gravity-2.0gemini-sparkai-search-modeuniversal-cartaudio-glassesgemini-for-sciencebuild-with-gemini-xprizecerebras-ipowafer-scale-engineandrew-feldmanandre-karpathy-anthropicelon-musk-openai-lawsuitdementia-preventionfountain-lifeskipper-agentself-regulation-ai
Free account

Make this library yours

Reading is free for everyone. A free account adds the personal layer: save protocols, follow experts, and see how the other experts weigh in on this same topic.

Create a free accountSign in

Where the experts disagree — weekly

One email a week: the sharpest new disagreements and protocols from the library. No spam, unsubscribe anytime.

Educational summary of the cited expert source — not medical advice. Open the source recording linked above and consult a qualified physician before acting on any protocol.